|
| | Afatinib Impurity QJJ Basic information |
| Product Name: | Afatinib Impurity QJJ | | Synonyms: | Afatinib Impurity QJJ;Afatinib Impurity 103;Butanamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-3-hydroxy-;Afatinib Impurity AFT-8Q: What is
Afatinib Impurity AFT-8 Q: What is the CAS Number of
Afatinib Impurity AFT-8;N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)-3-hydroxybutanamide (Afatinib Impurity) | | CAS: | 2323570-72-3 | | MF: | C24H27ClFN5O4 | | MW: | 503.95 | | EINECS: | | | Product Categories: | | | Mol File: | 2323570-72-3.mol |  |
| | Afatinib Impurity QJJ Chemical Properties |
| Boiling point | 702.1±60.0 °C(Predicted) | | density | 1.414±0.06 g/cm3(Predicted) | | solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly, Sonicated) | | pka | 12.84±0.43(Predicted) | | form | Solid | | color | White to Off-White | | Stability: | Stable under recommended storage conditions., Stable Under Recommended Storage C |
| | Afatinib Impurity QJJ Usage And Synthesis |
| Uses | Afatinib Impurity AFT-8 is an impurity of its parent compound Afatinib (A355300), which is an aminocrotonylamino-substituted quinazoline derivative used for treating cancer and diseases of the respiratory tract, lungs, gastrointestinal tract, bile duct, and gallbladder. |
| | Afatinib Impurity QJJ Preparation Products And Raw materials |
|
